- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01894100
Shoe Lifts for Leg Length Inequality in Adults With Knee or Hip Symptoms
Defining and Correcting Limb Length Inequality in Adults With Knee or Hip Symptoms
Study Overview
Status
Intervention / Treatment
Detailed Description
The purpose of this study is to examine the optimal clinical assessment method(s) for leg length inequality (LLI), determine if there is an association between foot posture (flat foot, normal, and high arch) and LLI, and gather preliminary data on lift therapy as a treatment for LLI and knee/hip symptoms. The specific aims of the project are as follows:
Specific Aim 1: Determine the validity and reliability of 4 clinical methods for assessing LLI.
Specific Aim 2: Determine differences in static and dynamic foot postures between longer and shorter limbs.
Specific Aim 3: Assess the feasibility of conducting a specific lift therapy intervention among individuals with a LLI and knee or hip pain, refining procedures as needed.
Public Health Impact: Results from the proposed research will be used to: 1) improve diagnosis of LLI by providing evidence on the various assessment methods for the clinicians who most frequently use clinical methods (i.e., physical therapists, chiropractors, podiatrists, and primary care physicians), and 2) develop and test new non-pharmacologic/non-invasive intervention strategies aimed at reducing pain and improving function in individuals with osteoarthritis and LLI.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Smithfield, North Carolina, United States, 27577
- UNC-CH Thurston Arthritis Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- participants from the Johnston County Osteoarthritis Project who have been previously identified to have a LLI and knee or hip symptoms
Exclusion Criteria:
- hospitalized for stroke, myocardial infarction, coronary artery revascularization, or diagnosis of metastatic cancer in the past 3 months
- terminal illness
- rheumatoid arthritis, severe fibromyalgia, or other systemic rheumatic disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Delayed Intervention Group
This group will not receive shoe lifts during the first 3 months after baseline.
At 3 months, they will begin the shoe lift correction for leg length inequality.
|
Lift therapy will be administered by a physical therapist.
Heel lifts and full length inserts used inside participants' shoes will be constructed on-site.
If an external shoe lift is required for a participant, a local shoe repair shop will construct the lifts and add them to the outside of the shoe.
Participants will be required to wear the lift in their shoes when they are walking or standing while enrolled in the study; participants will keep a daily diary to record their compliance (number of hours lift worn per day, amount of lift used, type of shoes worn, general symptoms experienced, and activities performed).
They will be contacted weekly to be reminded to increase their lift height and identify when they have achieved their optimal lift height.
|
Experimental: Immediate Intervention Group
At baseline, participants in this group will begin shoe lift correction for leg length inequality.
|
Lift therapy will be administered by a physical therapist.
Heel lifts and full length inserts used inside participants' shoes will be constructed on-site.
If an external shoe lift is required for a participant, a local shoe repair shop will construct the lifts and add them to the outside of the shoe.
Participants will be required to wear the lift in their shoes when they are walking or standing while enrolled in the study; participants will keep a daily diary to record their compliance (number of hours lift worn per day, amount of lift used, type of shoes worn, general symptoms experienced, and activities performed).
They will be contacted weekly to be reminded to increase their lift height and identify when they have achieved their optimal lift height.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Pain Intensity
Time Frame: Baseline and 3 months after initiating intervention
|
Western Ontario and McMasters Universities Osteoarthritis Index pain subscale is a 5 item questionnaire that asks participants to rate their pain during walking, using stairs, in bed, sitting or lying, and standing.
Each item is rated by the participant as 0-4 (no pain to extreme pain).
Total scores on the pain subscale range from 0 to 20 (no pain to extreme pain).
|
Baseline and 3 months after initiating intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Lower Extremity Physical Function
Time Frame: Baseline and 3 months post intervention
|
For self-reported lower extremity physical function: Western Ontario and McMasters Universities Osteoarthritis Index physical function subscale.
The physical function subscale includes 17 items that ask about difficulty with stair use, rising from sitting, standing, bending, walking, getting in / out of a car, shopping, putting on / taking off socks, rising from bed, lying in bed, getting in / out of bath, sitting, getting on / off toilet, heavy household duties, and light household duties.
Participants rate each item on a scale of 0-4 (no difficulty to extreme difficulty.
Totals scores for this subscale range from 0-68 (no difficulty to extreme difficulty).
|
Baseline and 3 months post intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Yvonne M Golightly, PT, MS, PhD, University of North Carolina, Chapel Hill
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-0807
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom
-
National Yang Ming UniversityFar Eastern Memorial HospitalCompletedMedial Knee OsteoarthritisTaiwan
-
Hanlim Pharm. Co., Ltd.CompletedKnee OsteoarthritisKorea, Republic of